ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 04 Jun 2021 The OlympiA trial results show the benefits of a targeted drug in patients with early-stage breast cancer and inherited BRCA mutations. We spoke to Chair of the OlympiA steering committee Professor Andrew Tutt about the landmark ICR research that underpins this major breakthrough. Find out more Show/Hide
NCRI 2018: World-leading cancer researchers and clinicians gather in Glasgow 04 Nov 2018 This year The Institute of Cancer Research, London, is in Scotland to attend the National Cancer Research Institute (NCRI) annual conference. As the UK’s largest platform for cancer researchers, clinicians, industry and patients to showcase the latest advances in cancer research, the ICR will be reporting on the cutting-edge science throughout. Find out more Show/Hide
Doing more for deadly cancers: new push to improve pancreatic cancer treatment 24 Mar 2017 While survival from breast and prostate cancer is increasing, there has been barely any improvement for patients with a lesser-known type of the disease – pancreatic cancer. But a new precision medicine initiative is looking to change that. Find out more Show/Hide